| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.28 | 3e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0007 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |